IMMUNOREGULATORY CIRCUITS IN MAN
人类的免疫调节回路
基本信息
- 批准号:6511672
- 负责人:
- 金额:$ 27.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-07-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:CD antigens Sjogren's syndrome T lymphocyte autoradiography biological signal transduction cell migration cytokine enzyme linked immunosorbent assay gene expression human subject immunoregulation laboratory mouse leukocyte activation /transformation phosphorylation protein biosynthesis protein tyrosine kinase rheumatoid arthritis systemic lupus erythematosus tissue /cell culture
项目摘要
DESCRIPTION (Adapted from Investigator's abstract): Memory CD4 T-cells play
a key role in host defense as well as the triggering and maintaining of
inflammation. The triggering of the costimulatory signals plays a central
role in the generation of effective immune responses. The costimulatory
signals can be provided by a number of accessory molecules. Of the
costimulatory molecules, CD29/VLA, CD26, and CD27 have been established by
this group. CD29/VLA and CD26 are preferentially expressed on CD4 memory
T-cells and play an important role in the costimulation, function, and
migration of memory T-cells. Much remains to be clarified regarding the
complex functions of CD29/VLA and CD26 in signal transduction and the
subsequent effects upon T-cell function and cell migration. The major goal
of this application is to determine the immunoregulatory circuits in man.
The specific aims of this application are: 1) The molecular basis of
CD29/VLA in T-cell costimulation, signaling and T-cell function. They will
define the structural basis of Cas-L tyrosine phosphorylation and FAK
activation and define the role of Cas-L in CD29/VLA-mediated cytokine
production and gene expression. Moreover, the role of Cas-L in T-cell
migration will be defined. 2) The molecular basis of CD26/DPPIV in T-cell
function and costimulation. The role of CD26/DPPIV in T-cell migration, the
precise characteristics of the binding of ADA to CD26, and the functional
significance of ADA in T-cell activation will be defined. In addition, the
structure and function of the ligand of CD26 other than ADA will be defined.
3), The molecular and cellular defects in patients with autoimmune diseases.
Analysis of VLA-mediated costimulation in patients with autoimmune diseases
will be performed. Moreover, the expression and function, of Cas-L, and FAK
as well as the migratory activity of T-cells in autoimmune diseases will be
determined. In addition, the level of CD26/DPPIV in serum/plasma and its
correlation with clinical complications in autoimmune diseases will be
defined. The study will not only provide new insights into understanding of
the mechanisms of T-cell activation and migration, but will also provide new
insights into understanding the precise molecular mechanisms of immune
abnormalities found in various autoimmune diseases and will lead to the
development of rational therapy for the manipulation of the abnormalities
found in such diseases.
描述(改编自研究人员摘要):记忆中的CD4T细胞发挥作用
在宿主防御以及触发和维护
发炎。共刺激信号的触发起到了中心作用
在产生有效的免疫反应方面发挥作用。共刺激作用
信号可以由许多辅助分子提供。中的
共刺激分子CD29/VLA、CD26和CD27已经由
这群人。CD29/VLA和CD26在CD4记忆体上优先表达
T细胞在共刺激、功能和免疫调节中发挥重要作用。
记忆T细胞的迁移。关于这一点还有很多需要澄清的地方
CD29/VLA和CD26在信号转导中的复杂功能及其机制
对T细胞功能和细胞迁移的后续影响。主要目标是
这一应用的目的是确定人的免疫调节回路。
本申请的具体目的是:1)分子基础
CD29/VLA在T细胞共刺激、信号转导和T细胞功能中的作用他们会
确定CaS-L酪氨酸磷酸化和FAK的结构基础
Cas-L在CD29/VLA介导的细胞因子中的激活及作用
生产和基因表达。此外,CaS-L在T细胞中的作用
将定义迁移。2)CD26/DPPIV在T细胞中的分子基础
功能和共刺激作用。CD26/DPPIV在T细胞迁移中的作用
ADA与CD26结合的精确特征及其功能
ADA在T细胞激活中的意义将被明确。此外,
将定义除ADA以外的CD26配体的结构和功能。
3)自身免疫性疾病患者的分子和细胞缺陷。
自身免疫性疾病患者VLA介导的共刺激作用分析
将会被执行。此外,CaS-L和FAK的表达和功能
以及自身免疫性疾病中T细胞的迁移活性
下定决心。此外,血清/血浆中CD26/DPPIV水平及其与CD26/DPPIV的相关性
与自身免疫性疾病临床并发症的相关性将是
已定义。这项研究不仅将为理解
T细胞活化和迁移的机制,但也将提供新的
对理解免疫的精确分子机制的见解
在各种自身免疫性疾病中发现的异常,并将导致
畸形手法的合理治疗进展
在这类疾病中发现。
项目成果
期刊论文数量(92)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
- DOI:10.4049/jimmunol.147.9.2825
- 发表时间:1991-11
- 期刊:
- 影响因子:4.4
- 作者:Nam H. Dang;Y. Torimoto;K. Shimamura;Takashi Tanaka;Jennifer Daley;S. F. Schlossman;Chikao Morimoto
- 通讯作者:Nam H. Dang;Y. Torimoto;K. Shimamura;Takashi Tanaka;Jennifer Daley;S. F. Schlossman;Chikao Morimoto
CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling.
- DOI:10.4049/jimmunol.159.6.2652
- 发表时间:1997-09
- 期刊:
- 影响因子:4.4
- 作者:S. Jacquot;T. Kobata;S. Iwata;C. Morimoto;S. Schlossman
- 通讯作者:S. Jacquot;T. Kobata;S. Iwata;C. Morimoto;S. Schlossman
Cas-L is required for beta 1 integrin-mediated costimulation in human Tcells.
Cas-L 是人类 T 细胞中 β1 整合素介导的共刺激所必需的。
- DOI:
- 发表时间:1999
- 期刊:
- 影响因子:0
- 作者:Kamiguchi,K;Tachibana,K;Iwata,S;Ohashi,Y;Morimoto,C
- 通讯作者:Morimoto,C
Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system.
VLA/CD29分子的交联与抗CD3对无血清培养系统中CD4细胞的活化具有共同有丝分裂作用。
- DOI:10.1002/eji.1830210212
- 发表时间:1991
- 期刊:
- 影响因子:5.4
- 作者:Yamada,A;Nojima,Y;Sugita,K;Dang,NH;Schlossman,SF;Morimoto,C
- 通讯作者:Morimoto,C
Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells.
开发单克隆抗体抗 6C2,该抗体参与 CD4 T 辅助细胞和活化 B 细胞的相互作用。
- DOI:
- 发表时间:1991
- 期刊:
- 影响因子:0
- 作者:Torimoto,Y;Sugita,K;Weinberg,DS;Dang,NH;Donahue,C;Letvin,NL;Schlossman,SF;Morimoto,C
- 通讯作者:Morimoto,C
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chikao Morimoto其他文献
Chikao Morimoto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chikao Morimoto', 18)}}的其他基金
CHARACTERIZATION OF IMMUNOREGULATORY T CELLS POST ALLOGENIC BMT
同种异体 BMT 后免疫调节 T 细胞的表征
- 批准号:
6099462 - 财政年份:1998
- 资助金额:
$ 27.44万 - 项目类别:
CHARACTERIZATION OF IMMUNOREGULATORY T CELLS POST ALLOGENIC BMT
同种异体 BMT 后免疫调节 T 细胞的表征
- 批准号:
6234962 - 财政年份:1997
- 资助金额:
$ 27.44万 - 项目类别:
STRUCTURE AND FUNCTION OF THE HUMAN DPPIV/CD26 MOLECULE
人 DPPIV/CD26 分子的结构和功能
- 批准号:
2096730 - 财政年份:1993
- 资助金额:
$ 27.44万 - 项目类别:
STRUCTURE AND FUNCTION OF THE HUMAN DPPIV/CD26 MOLECULE
人 DPPIV/CD26 分子的结构和功能
- 批准号:
3200109 - 财政年份:1993
- 资助金额:
$ 27.44万 - 项目类别:
STRUCTURE AND FUNCTION OF THE HUMAN DPPIV/CD26 MOLECULE
人 DPPIV/CD26 分子的结构和功能
- 批准号:
2096731 - 财政年份:1993
- 资助金额:
$ 27.44万 - 项目类别:
CHARACTERIZATION OF THE IMMUNOREGULATORY CIRCUITS IN MAN
人类免疫调节回路的特征
- 批准号:
3156631 - 财政年份:1985
- 资助金额:
$ 27.44万 - 项目类别:
CHARACTERIZATION OF THE IMMUNOREGULATORY CIRCUITS IN MAN
人类免疫调节回路的特征
- 批准号:
3156633 - 财政年份:1985
- 资助金额:
$ 27.44万 - 项目类别:
CHARACTERIZATION OF THE IMMUNOREGULATORY CIRCUITS IN MAN
人类免疫调节回路的特征
- 批准号:
3156626 - 财政年份:1985
- 资助金额:
$ 27.44万 - 项目类别:
相似海外基金
Exploring Roles for Transcription Factor Ets1 in Sjogren's Syndrome
探索转录因子 Ets1 在干燥综合征中的作用
- 批准号:
10644080 - 财政年份:2023
- 资助金额:
$ 27.44万 - 项目类别:
Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome
衰老和氧化应激对干燥综合征唾液腺疾病的影响
- 批准号:
10682148 - 财政年份:2023
- 资助金额:
$ 27.44万 - 项目类别:
Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome
控制干燥综合征的自身免疫炎症并促进唾液腺再生
- 批准号:
10528045 - 财政年份:2022
- 资助金额:
$ 27.44万 - 项目类别:
Harnessing molecular signatures to deliver personalised B-cell targeted therapies in Sjogren's syndrome
利用分子特征为干燥综合征提供个性化 B 细胞靶向治疗
- 批准号:
MR/X004694/1 - 财政年份:2022
- 资助金额:
$ 27.44万 - 项目类别:
Research Grant
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome
用鲁索替尼靶向内源性间充质基质细胞治疗干燥综合征的唾液腺炎
- 批准号:
10646349 - 财政年份:2022
- 资助金额:
$ 27.44万 - 项目类别:
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome
用鲁索替尼靶向内源性间充质基质细胞治疗干燥综合征的唾液腺炎
- 批准号:
10524424 - 财政年份:2022
- 资助金额:
$ 27.44万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10685136 - 财政年份:2022
- 资助金额:
$ 27.44万 - 项目类别:
Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome
控制干燥综合征的自身免疫炎症并促进唾液腺再生
- 批准号:
10657745 - 财政年份:2022
- 资助金额:
$ 27.44万 - 项目类别:
Development of remote support program to improve sleep quality and fatigue in patients with Sjogren's syndrome
开发远程支持计划以改善干燥综合征患者的睡眠质量和疲劳
- 批准号:
21K10778 - 财政年份:2021
- 资助金额:
$ 27.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)